A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma.

Heng MeiChenggong LiHuiwen JiangXinying ZhaoZhiping HuangDan JinTao GuoHaiming KouLin LiuLu TangPing YinZhihui WangLisha AiSha KeYimeng XiaJun DengLei ChenLi CaiChunyan SunLinghui XiaGaoquan HuaYu Hu

Published in: Journal of hematology & oncology (2021)

Chictr.org.cn ChiCTR1800018143.

Keyphrases

cell therapy
multiple myeloma
stem cells
mesenchymal stem cells
lymph node metastasis
cancer therapy
nk cells
acute lymphoblastic leukemia
acute myeloid leukemia
squamous cell carcinoma
hodgkin lymphoma
drug delivery